0.1010SEK-9.01%Mkt Cap: 134.71M SEKP/E: —Last update: 2026-05-13
Simris Group AB (PUBL), a biotechnology company, develops antibody-drug conjugate (ADC) payloads in Sweden and internationally. The company develops, manufactures, and sells bioactive substances from cultured microalgae …
Industry Peers
Biotechnologyloading…
Indicators:|
Key Statistics
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
P/B-99.80
P/S50.91
EV/EBITDA-5.26
EV/Revenue27.70
EPS (TTM)-0.04
EPS (Forward)—
Cash Flow & Leverage
FCF Yield-10.03%
FCF Margin-510.81%
Operating CF-16.05M SEK
CapEx (TTM)224.00K SEK
Net Debt/EBITDA0.77
Net Debt-10.76M SEK
Technical
SMA 500.0933 (+8.2%)
SMA 2000.1003 (+0.7%)
Beta—
S&P 52W Chg24.23%
Avg Vol (30d)165.96K
Avg Vol (10d)316.09K
Technical Indicators
RSI (14)55.2
MACD0.0023
MACD Signal-0.0002
MACD Hist.+0.0025
BB Upper0.1063 SEK
BB Middle0.0898 SEK
BB Lower0.0733 SEK
BB Width36.73%
ATR (14)0.0151 SEK
Vol Ratio (20d)0.64x
52W Range
0.040228% of range0.2610
52W High0.2610 SEK
52W Low0.0402 SEK
Profitability
Gross Margin109.29%
EBITDA Margin0.00%
Profit Margin-1660.12%
Oper. Margin-472.77%
ROE5704.47%
ROA-18.07%
Revenue Growth648.40%
Earnings Growth—
Balance Sheet
Debt/Equity-5.44
Current Ratio0.99
Quick Ratio0.90
Book Value/Sh-0.0010 SEK
Cash/Share0.0130 SEK
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 SEK
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Ownership
Shares Out.1.35B
Float760.49M
Insiders7.24%
Institutions0.44%
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Company
Market Cap134.71M SEK
Enterprise Value73.28M SEK
Revenue (TTM)2.65M SEK
Gross Profit1.76M SEK
Net Income (TTM)-26.81M SEK
Revenue/Share0.0030 SEK
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees5
Last Price0.1010 SEK
CountrySE
SectorHealthcare
IndustryBiotechnology
ISIN—